Lancet neurology

• Latest
• Best
• Search…

• Lancet neurology · Apr 2013

  Comment Letter

  Authors' reply. Subthalamic versus globus pallidus deep brain stimulation.

  no abstract available

  keep reading… mark as read…

• Lancet neurology · Apr 2013

  Comment

  Quantifying an amyloid β model for Alzheimer's disease.

  no abstract available

  read on… or not…

• Lancet neurology · Apr 2013

  Comment

  Extended-release carbidopa-levodopa in Parkinson's disease.

  no abstract available

  expand abstract… or not…

• Lancet neurology · Apr 2013

  Olga Ciccarelli.

  no abstract available

  read more… or not…

• Lancet neurology · Apr 2013

  Randomized Controlled Trial Multicenter Study Comparative Study

  Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.

  IPX066 is an oral, extended-release, capsule formulation of carbidopa-levodopa. We aimed to assess this extended-release formulation versus immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations. ⋯ Impax Laboratories.

  expand abstract… mark as read…